Cargando…
Serum DBI and biomarkers of neuroinflammation in Alzheimer’s disease and delirium
BACKGROUND: Alzheimer’s disease (AD) patients often express significant behavioral symptoms: for this reason, accessible related biomarkers could be very useful. Neuroinflammation is a key pathogenic process in both AD and delirium (DEL), a clinical condition with behavioral symptoms resembling thos...
Autores principales: | Conti, Elisa, Andreoni, Simona, Tomaselli, Davide, Storti, Benedetta, Brovelli, Francesco, Acampora, Roberto, Da Re, Fulvio, Appollonio, Ildebrando, Ferrarese, Carlo, Tremolizzo, Lucio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870594/ https://www.ncbi.nlm.nih.gov/pubmed/32705487 http://dx.doi.org/10.1007/s10072-020-04608-x |
Ejemplares similares
-
Blood-Based Biomarkers of Neuroinflammation in Alzheimer’s Disease: A Central Role for Periphery?
por: Angiulli, Federica, et al.
Publicado: (2021) -
Delirium in your house: a survey during General Practitioner-programmed home visits
por: Tremolizzo, Lucio, et al.
Publicado: (2021) -
Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review
por: Pozzi, Federico Emanuele, et al.
Publicado: (2022) -
ALS Mimics due to Affection of the Cervical Spine: From Common Compressive Myelopathy to Rare CSF Epidural Collection
por: Storti, Benedetta, et al.
Publicado: (2021) -
Tics: neurological disorders determined by a deficit in sensorimotor gating processes
por: Schilke, Edoardo Dalmato, et al.
Publicado: (2022)